Skip to main content

Peer Review reports

From: Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial

Original Submission
11 Feb 2018 Submitted Original manuscript
2 Jun 2018 Reviewed Reviewer Report - Michael Tvilling Madsen
10 Jun 2018 Reviewed Reviewer Report - Zhiqing He
16 Aug 2018 Author responded Author comments - Gang Wang
Resubmission - Version 2
16 Aug 2018 Submitted Manuscript version 2
21 Aug 2018 Reviewed Reviewer Report - Zhiqing He
28 Aug 2018 Reviewed Reviewer Report - Michael Tvilling Madsen
3 Sep 2018 Author responded Author comments - Jingjing Zhou
Resubmission - Version 3
3 Sep 2018 Submitted Manuscript version 3
Publishing
11 Dec 2018 Editorially accepted
9 Jan 2019 Article published 10.1186/s13063-018-3132-3

You can find further information about peer review here.

Back to article page